IP Library Granted Patent US 9,522,365
Granted Patent B2
US 9,522,365 · App. 12/523,323 · Granted Dec 20, 2016

Cross-linked cellulose membranes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,365
App. No.
12/523,323
Granted
Dec 20, 2016
Kind
B2
Abstract

The invention relates to a process for making porous cross-linked charged cellulosic polymeric membranes capable of binding to a target molecule. The invention provides methods for separating target molecules from other components in a solution comprising use of membranes obtainable by the process of the invention. The method has particular utility in separating proteins and nucleic acids from cell lysates and cultures.

Claims (11)

1. A process for making a porous cross-linked charged cellulosic polymeric membrane comprising:

i) adding a base to a porous cellulose acetate membrane comprising a plurality of acetate groups in the presence of a solution of 0.25-2% epichlorohydrin to cross-link said cellulose acetate therein to provide a cross-linked cellulose acetate membrane, and

ii) reacting said cross-linked membrane with glycidyl trimethylammonium chloride to introduce a positively charged group

wherein said process is carried out in the presence of sodium sulfate, and the resulting porous cross-linked charged cellulosic polymeric membrane comprises a plurality of cellulose acetate groups and swells from 40% to 250% by volume in a solution of water.

2. The process of claim 1 , wherein the resulting cross-linked cellulosic membrane swells by 125% to 250% by volume in a solution of water.

3. The process of claim 1 , wherein said base is selected from the group consisting of sodium hydroxide, potassium hydroxide, calcium hydroxide, barium hydroxide, tetraalkylammonium hydroxide, sodium carbonate, calcium carbonate, sodium triphosphate, sodium silicate, potassium carbonate, potassium silicate, potassium triphosphate and sodium hydrogen carbonate.

4. The process of claim 1 , wherein the membrane comprises pores having a pore size of 0.1 to 10 microns.

5. The process of claim 1 , wherein the base is sodium hydroxide.

6. The process of claim 1 , wherein the crosslinking process is carried out at 20° C. to 60° C. for a period of at least 1 hour.

7. The process of claim 6 , wherein the crosslinking process is carried out at a temperature of 45° C. to 55° C. for a period of at least 1 hour.

8. The process of claim 1 , wherein said ligand comprises a positively charged group and wherein the resulting porous cross-linked charged cellulosic polymeric membrane has a dynamic BSA capacity of at least 30 mg/ml.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2009
From: RUDSTEDT, ASA; AXEN, ANDREAS; NORRMAN, NILS; LARSSON, ANDERS
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 022962/0661 →